{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:57:06Z","timestamp":1791518226959,"version":"4.3.4"},"reference-count":47,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Pemphigus vulgaris is an autoimmune disease that occurs due to pathogenic autoantibodies that recognize the following epidermal adhesion proteins: desmogleins. Systemic corticosteroids usually decrease the titers of anti-desmoglein autoantibodies and improve patients\u2019 conditions. Since modifications of IgG N-glycosylation have been described in some autoimmune diseases, we hypothesized that changes in the pathogenic activity of pemphigus IgG could be related to changes in their N-glycosylation profile. The purpose of this study was to assess, longitudinally, the pathogenicity of pemphigus serum IgG and their N-glycosylation profile during phases of disease activity and clinical remission. The pathogenic activity of serum IgG was measured in vitro on immortalized keratinocytes, by immunofluorescence and dissociation assays, and IgG N-glycans were analyzed by mass spectrometry. We showed (i) a correlation between pemphigus clinical activity and the pathogenicity of serum IgG at baseline and at month 6, while the persistence of the in vitro pathogenic activity of IgG during its evolution, even in patients in clinical remission, seemed to be predictive of relapse; (ii) that modifications of the N-glycan structure were altered the in vitro pathogenicity of patients\u2019 autoantibodies; (iii) that the pathogenic properties of pemphigus IgG did not appear to be related to the disparity in IgG N-glycans during the course of pemphigus.<\/jats:p>","DOI":"10.3390\/biomedicines9101411","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T23:37:08Z","timestamp":1633822628000},"page":"1411","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-3997","authenticated-orcid":false,"given":"Marie","family":"Petit","sequence":"first","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1031-1916","authenticated-orcid":false,"given":"Marie-Laure","family":"Walet-Balieu","sequence":"additional","affiliation":[{"name":"EA4358, Laboratoire Glycobiologie et Matrice Extracellulaire V\u00e9g\u00e9tale (Glyco-MEV), Normandie University, 76821 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8612-8536","authenticated-orcid":false,"given":"Damien","family":"Schapman","sequence":"additional","affiliation":[{"name":"PRIMACEN, Normandie University, 76821 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-5345","authenticated-orcid":false,"given":"Marie-Laure","family":"Golinski","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"},{"name":"Dermatology Department, Rouen University Hospital, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Burel","sequence":"additional","affiliation":[{"name":"EA4358, Laboratoire Glycobiologie et Matrice Extracellulaire V\u00e9g\u00e9tale (Glyco-MEV), Normandie University, 76821 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Barray","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2879-9304","authenticated-orcid":false,"given":"Laurent","family":"Drouot","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-2792","authenticated-orcid":false,"given":"Maud","family":"Maho-Vaillant","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"},{"name":"Dermatology Department, Rouen University Hospital, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-2033","authenticated-orcid":false,"given":"Vivien","family":"H\u00e9bert","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"},{"name":"Dermatology Department, Rouen University Hospital, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-307X","authenticated-orcid":false,"given":"Olivier","family":"Boyer","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-903X","authenticated-orcid":false,"given":"Muriel","family":"Bardor","sequence":"additional","affiliation":[{"name":"EA4358, Laboratoire Glycobiologie et Matrice Extracellulaire V\u00e9g\u00e9tale (Glyco-MEV), Normandie University, 76821 Rouen, France"},{"name":"CNRS UMR 8576, Unit\u00e9 de Glycobiologie Structurale et Fonctionnelle, University of Lille, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"},{"name":"Dermatology Department, Rouen University Hospital, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4358-8417","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Calbo","sequence":"additional","affiliation":[{"name":"INSERM U1234, Normandie University, 76000 Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/1523-1747.ep12277362","article-title":"Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB\/c mice by passive transfer","volume":"85","author":"Roscoe","year":"1985","journal-title":"J. Investig. Dermatol."},{"key":"ref_4","first-page":"749","article-title":"Neonatal pemphigus vulgaris","volume":"18","author":"Drerup","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus vulgaris in pregnancy: Analysis of current data on the management and outcomes","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2018.00097","article-title":"A New Classification System for IgG4 Autoantibodies","volume":"9","author":"Koneczny","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2133.2000.03659.x","article-title":"The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives","volume":"143","author":"Kricheli","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00403-007-0760-y","article-title":"Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: Coincidental phenomenon with a risk of disease development?","volume":"299","author":"Torzecka","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e140453","DOI":"10.1172\/JCI140453","article-title":"Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy","volume":"131","author":"Haddad","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.imlet.2006.05.011","article-title":"Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody","volume":"106","author":"Liu","year":"2006","journal-title":"Immunol. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The Emerging Importance of IgG Fab Glycosylation in Immunity","volume":"196","author":"Hafkenscheid","year":"2016","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrrheum.2017.146","article-title":"Differential antibody glycosylation in autoimmunity: Sweet biomarker or modulator of disease activity?","volume":"13","author":"Seeling","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ebiom.2017.01.033","article-title":"Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis","volume":"17","author":"Kemna","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/prca.201500089","article-title":"Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease","volume":"10","author":"Miyoshi","year":"2016","journal-title":"Proteom. Clin. Appl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/art.39273","article-title":"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome","volume":"67","author":"Vuckovic","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): A prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"ref_25","first-page":"31","article-title":"Rituximab and Corticosteroid Effect on Desmoglein-Specific B-Cells and Desmoglein-Specific T-Follicular-Helper-Cells in Pemphigus","volume":"16","author":"Perals","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.0022-202X.2005.23714.x","article-title":"In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris","volume":"124","author":"Ishii","year":"2005","journal-title":"J. Investig Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"28820","DOI":"10.1038\/srep28820","article-title":"Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes","volume":"6","author":"Vollner","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jbiotec.2011.09.023","article-title":"IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines","volume":"157","author":"Ho","year":"2012","journal-title":"J. Biotechnol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10156","DOI":"10.1038\/s41598-017-10698-z","article-title":"Heterologous expression of the N-acetylglucosaminyltransferase I dictates a reinvestigation of the N-glycosylation pathway in Chlamydomonas reinhardtii","volume":"7","author":"Vanier","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13007-018-0374-8","article-title":"User-friendly extraction and multistage tandem mass spectrometry based analysis of lipid-linked oligosaccharides in microalgae","volume":"14","author":"Lucas","year":"2018","journal-title":"Plant Methods"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/glycob\/cwz045","article-title":"Updates to the Symbol Nomenclature for Glycans guidelines","volume":"29","author":"Neelamegham","year":"2019","journal-title":"Glycobiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrd2804","article-title":"Glycosylation as a strategy to improve antibody-based therapeutics","volume":"8","author":"Jefferis","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mahan, A.E., Jennewein, M.F., Suscovich, T., Dionne, K., Tedesco, J., Chung, A.W., Streeck, H., Pau, M., Schuitemaker, H., and Francis, D. (2016). Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005456"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"M111.014563","DOI":"10.1074\/mcp.M111.014563","article-title":"Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination","volume":"11","author":"Selman","year":"2012","journal-title":"Mol. Cell Proteom."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni.3579","article-title":"Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease","volume":"18","author":"Pfeifle","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.bbadis.2018.03.018","article-title":"Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10years of follow-up","volume":"1864","author":"Gudelj","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.bbagen.2016.03.035","article-title":"Towards personalized diagnostics via longitudinal study of the human plasma N-glycome","volume":"1860","author":"Hennig","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1038\/s41598-017-08654-y","article-title":"Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation","volume":"7","author":"Sonneveld","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4049\/jimmunol.162.4.2162","article-title":"Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1\u21926) dextran antibody","volume":"162","author":"Coloma","year":"1999","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj3380529","article-title":"Variable domain-linked oligosaccharides of a human monoclonal IgG: Structure and influence on antigen binding","volume":"338","author":"Leibiger","year":"1999","journal-title":"Biochem. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.168.3.1099","article-title":"Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen","volume":"168","author":"Wallick","year":"1988","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E2567","DOI":"10.1073\/pnas.1406974111","article-title":"Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity","volume":"111","author":"Sabouri","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13075-016-1172-1","article-title":"Fab glycosylation of immunoglobulin G does not associate with improvement of rheumatoid arthritis during pregnancy","volume":"18","author":"Bondt","year":"2016","journal-title":"Arthritis Res. Ther."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1411\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:24Z","timestamp":1760166624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101411"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101411","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]}}}